Editorial: Stem cell institute responsive, to a point
By Sacramento Bee,
Sacramento Bee
| 02. 14. 2006
Six months ago, California's $3 billion stem cell research institute appeared to be an agency in denial.
Lawsuits prevented the institute from issuing research grants. Less litigious critics prodded its oversight committee to enact stronger rules on research ethics, intellectual property and conflicts of interest.
Instead of dealing with those issues, Chairman Robert Klein spent his time courting philanthropists and hiring a P.R. firm on a $378,000 no-bid contract. The agency's priorities were completely skewed.
On Friday, Klein and the oversight committee took a big step toward reversing past mistakes and demonstrating they can operate as an open, responsive public body. After listening to public interest groups, ethicists and legislators, the 29-member committee approved policies on medical standards and commercial licensing of stem cell therapies that, while not perfect, are a vast improvement over where the institute was heading just a few months ago.
Consider the issue of egg providers. To create lines of stem cells for research, scientists will need women to provide eggs, possibly thousands of them. Proposition 71 explicitly prohibits "compensation" for egg providers, with good reason...
Related Articles
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Neel Shah, The Preprint | 04.11.2024
Years ago, I interviewed for a residency position at The Johns Hopkins Hospital in Baltimore. Standing before the domed Victorian building at the campus entrance, I couldn’t help but be in awe of the history of the place, the great...
By Eleanor Hayward and Joanna Crawford, The Times | 03.29.2024
Gazing out at the Mediterranean from an idyllic rocky mountaintop, Sophie Hermann announced to her half a million Instagram followers that she had decided to freeze her eggs. Since that post in August, the 37-year-old former Made in Chelsea star...